Skip to content

The study of syndrome characteristics and coupling of herbal formula and syndrome about qi-deficiency and blood-stasis syndrome based on proteomics

The study of syndrome characteristics and coupling of herbal formula and syndrome about qi-deficiency and blood-stasis syndrome of coronary heart disease based on proteomics

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002924
Enrollment
Unknown
Registered
2012-12-29
Start date
2010-02-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

Group A:Basical treatment plus Huoxue baoxin pills
Group B:Basical treatment plus "Bianzhen Lunzhi"

Sponsors

The First Hospital of Tianjin University of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. conform to the diagnosis of coronary heart disease, angina; 2. accord with TCM syndrome diagnosis standard; 3. anginal attacks > 2 times in patients with angina pectoris Weekly; 4. Age control between 40 and 80 years old; 5. signed consent to know.

Exclusion criteria

Exclusion criteria: 1. severe cardiopulmonary function is not complete, severe arrhythmia (rapid atrial fibrillation, room robot, paroxysmal chamber speed, II°type II above atrioventricular block, completeness bundle branch block) person; 2. normal ecg have ST - T change, no objective basis for coronary heart disease, such as coronary angiography, nuclide myocardium scanning positive index and no history of heart attack the joint; 3. combined liver, kidney, hematopoietic system serious primary disease, liver function (ALT, AST) > sixty u/L person, kidney was abnormal; 4. the pregnancy or lactation women; 5. psychiatric patients or other can't match with the experimenter; 6. allergic constitution or have a variety of drug allergy patients.

Design outcomes

Primary

MeasureTime frame
Disease index;Syndrome indicator;

Countries

China

Contacts

Public ContactYingzhi Xu
xufanyingzhi@163.com+86 15022185610

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026